ANL 23.10 Decreased By ▼ -0.70 (-2.94%)
ASC 16.10 Decreased By ▼ -0.30 (-1.83%)
ASL 22.25 Decreased By ▼ -0.40 (-1.77%)
BOP 8.55 Increased By ▲ 0.17 (2.03%)
BYCO 8.96 Increased By ▲ 0.15 (1.7%)
FCCL 18.07 Decreased By ▼ -0.40 (-2.17%)
FFBL 24.45 Decreased By ▼ -0.15 (-0.61%)
FFL 17.90 Decreased By ▼ -0.15 (-0.83%)
FNEL 8.40 Decreased By ▼ -0.14 (-1.64%)
GGGL 22.09 Decreased By ▼ -0.21 (-0.94%)
GGL 43.18 Decreased By ▼ -0.77 (-1.75%)
HUMNL 7.02 Decreased By ▼ -0.15 (-2.09%)
JSCL 20.85 Decreased By ▼ -0.73 (-3.38%)
KAPCO 37.90 Decreased By ▼ -0.20 (-0.52%)
KEL 3.61 Increased By ▲ 0.01 (0.28%)
MDTL 3.00 Decreased By ▼ -0.07 (-2.28%)
MLCF 36.30 Decreased By ▼ -0.18 (-0.49%)
NETSOL 153.30 Decreased By ▼ -4.45 (-2.82%)
PACE 5.98 Decreased By ▼ -0.03 (-0.5%)
PAEL 31.20 Decreased By ▼ -0.45 (-1.42%)
PIBTL 9.36 Decreased By ▼ -0.11 (-1.16%)
POWER 7.90 Decreased By ▼ -0.14 (-1.74%)
PRL 20.85 Decreased By ▼ -0.13 (-0.62%)
PTC 10.40 Increased By ▲ 0.02 (0.19%)
SILK 1.67 Decreased By ▼ -0.02 (-1.18%)
SNGP 43.19 Decreased By ▼ -0.56 (-1.28%)
TELE 22.06 Decreased By ▼ -0.64 (-2.82%)
TRG 173.50 Decreased By ▼ -2.41 (-1.37%)
UNITY 36.20 Decreased By ▼ -0.77 (-2.08%)
WTL 3.25 Decreased By ▼ -0.08 (-2.4%)
BR100 4,979 Decreased By ▼ -47.44 (-0.94%)
BR30 24,460 Decreased By ▼ -312.8 (-1.26%)
KSE100 46,636 Decreased By ▼ -284.38 (-0.61%)
KSE30 18,480 Decreased By ▼ -177.85 (-0.95%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
27,072
6824hr
Pakistan Cases
1,218,749
2,92824hr
5.08% positivity
Sindh
448,658
Punjab
419,423
Balochistan
32,707
Islamabad
103,720
KPK
170,391
Business & Finance

Abbott first-quarter profit surges on COVID-19 test demand

  • A recovery in medical device sales as vaccinations encourage patients to opt for elective surgeries put off during the pandemic is now energizing the companies' top line.
  • In the latest quarter, Abbott's COVID-19 test kits generated sales of $2.2 billion and accounted for more than half of its diagnostic unit's revenue.
20 Apr 2021

Abbott Laboratories reported a more than threefold jump in quarterly profit on Tuesday, buoyed by robust demand for its COVID-19 test kits and a recovery in its medical devices business.

Abbott and rivals Quest Diagnostics and Becton Dickinson and Co have benefited from heightened COVID-19 testing, a revenue stream that helped blunt the blow from lower demand for medical devices during the early phase of the crisis.

A recovery in medical device sales as vaccinations encourage patients to opt for elective surgeries put off during the pandemic is now energizing the companies' top line.

In the latest quarter, Abbott's COVID-19 test kits generated sales of $2.2 billion and accounted for more than half of its diagnostic unit's revenue.

Worldwide nutrition sales increased 6.9% in the quarter, while medical device sales increased 13.1%, led by Abbott's blood sugar monitoring device, FreeStyle Libre.

The company reiterated its 2021 adjusted diluted earnings per share outlook of at least $5.00.

Net earnings rose to $1.8 billion, or $1 per share, in the first quarter ended March 31, from $564 million, or 31 cents per share, a year earlier.

Net sales increased to $10.5 billion from $7.73 billion.

Comments

Comments are closed.